Loading asset research
Gossamer Bio Inc. Common Stock
GOSSNasdaq · USD · StocksQuote as of · Exchange session not verified$10.69
-6.12%
Today
GOSS
Loading 1D prices…
Market cap
$65.6M
Volume
471.8K
52w high
$309.6052w low
$9.10Company profile
Gossamer Bio Inc. Common Stock
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. The company develops GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
San Diego, CA, United States
Employees
161
Fiscal year end
1231
CIK
1728117
Session & valuation
Open$12.48
Previous close$11.39
Day high$12.52
Day low$10.47
30-day avg. volume244.3K
Outstanding shares488.8M
Diluted EPS-$0.75
Latest annual period
P/E (trailing)-14.26
P/E (forward)-0.69
Price / book-55.89
Beta2.00
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| SPROSpero Therapeutics Inc. Common Stock | $65.8M | $12.6M | +68.11% | $0.15 | +0.89% | Buy |
| DWTXDogwood Therapeutics Inc. Common Stock | $65.9M | $0.00 | — | -$7.13 | +3.19% | Buy |
| NMADNomad Power Solutions Inc. Common Stock | $64.7M | $0.00 | — | -$1.26 | -4.58% | Unrated |
| XBITXBiotech Inc. Common Stock | $66.8M | $0.00 | — | -$1.49 | +0.92% | Unrated |
| BOLDBoundless Bio Inc. Common Stock | $64.4M | $0.00 | — | -$2.60 | +0.00% | Hold |